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g.2013.0Abstract Sarcoidosis is a systemic granulomatous disease of unknown etiology that is character-
ized by the formation of noncaseating granulomas. Gastrointestinal (GI) tract involvement in sar-
coidosis is rare. Gastric sarcoidosis, particularly involving the antrum, affects approximately 10%
of patients with systemic disease. GI sarcoidosis commonly occurs subclinically, with clinical man-
ifestations present in only 0.1–0.9% of patients with the disease.
This is a rare case report of a 8 year Saudi girl with symptomatic gastric sarcoidosis. The patient
presented with anorexia, postprandial upper abdominal pain and fullness, and weight loss of
3 months duration. She was presented acutely after 6 months with attack of hematemesis. Endo-
scopic examination of upper gastrointestinal tract revealed bleeding nodular mucosal irregularities.
Mucosal biopsies revealed noncaseating granulomatous inflammation involving the gastric mucosa
confirming the diagnosis of sarcoidosis. Corticosteroid therapy was started and the symptoms aba-
ted almost immediately. We also offer a review of the literature.
 2013 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.Introduction
Sarcoidosis is a disease of undetermined cause that primarily
affects adults and is characterized by the formation of nonca-
seating granulomas. Proper interpretation of the biopsies is
crucial because tuberculosis, syphilis, Crohn disease, foreign
body reactions, and fungal infections can all present withPCH, P.O. Box 449, Alrdyia
.com (S.A. Sadek), Dr_faw
Shams University.
g by Elsevier
y. Production and hosting by Elsev
2.001granulomatous disease [1]. Although sarcoidosis is a multisys-
tem disease, involvement of alimentary tract is rare; when pres-
ent, it is often an asymptomatic finding in a patient with widely
disseminated disease. The etiology of sarcoidosis is unknown,
most experts think that sarcoidosis results from the exposure
of genetically susceptible hosts to specific environmental, occu-
pational or infectious agents that trigger an exaggerated cellu-
lar immune response, leading to granuloma formation.
Follow-up studies on chromosome 6 identified the BTNL2
gene to be associated with sarcoidosis [2].
This is a rare case report of a 8 year Saudi girl with symp-
tomatic gastric sarcoidosis presented with anorexia, upper
abdominal pain, weight loss of 3 months duration, and
6 months later presented with hematemesis and abated almost
immediately with corticosteroid treatment.ier B.V. All rights reserved.
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A Saudi girl (8 years old) presented with 3 month history of
anorexia, post prandial upper abdominal pain and fullness.
She was also complaining of generalized fatigue, early satiety,
paleness and weight loss of 5 kg in last 3 months. She denied
experiencing diarrhea, fever, rashes, joint pain, or respiratory
complaint. Her past medical history was unremarkable except
attacks of mild epistaxis. Her parents are nonconsanguineous
with no family history of gastrointestinal, food allergy autoim-
mune, tuberculosis, or malignant diseases.
On physical examination, she looked pale, no jaundice, her
weight on 25% centile, height on 50% centile, hepatomegaly
4 cm below costal margin. Vital signs were normal, no skin
rashes, no palpable lymph nodes and normal chest and neuro-
logical examinations .The investigations showed: WBCs
12.4 · 109/l, neutrophiles 35%, the Hb level was 6.4 gm/dl,
MCV 51%, RDW 17, retics 1.5%, platelets 520 · 109/l, Coo-
mbs test ve, Hb electrophoresis was normal, Iron profile:
iron 1.5 umol/l, transferrin 2.7 umol/l (N: 2.1–3.6), saturation
2%, CRP ve, ESR 50 mm/h, stool occult blood ve. Serum
electrolytes liver, renal, lipid profiles were normal, CXR
showed bilateral basal infiltrates with minimal left pleural effu-
sion. Ultrasonography of abdomen showed hepatomegaly with
iso-hypoechoic lesions in liver suggesting granulomatous dis-
ease as the primary possibility over malignant process, C.T
chest and abdomen showed multiple small mediastinal lymph
nodes; multiple small subpleural nodules scattered at both
lungs, hepatosplenomegaly with multiple small innumerable le-
sions at the liver. Tuberculin skin test was 9 mm, sputum and
gastric aspirate for acid fast bacilli stain and cultures were ve,
sweat test was 10 mm, immunoglobulin electrophoresis; nor-
mal, antibacterial antibodies within normal, nitroblue test;
normal, C50/100 normal, ANA ve, Hbs Ag; ve. Bone mar-
row examination showed normal cellularity with active trilin-
eage hematopoiesis. Liver biopsy showed nonspecific
granulomatous inflammatory reactions. She was put on antitu-
berculous therapy for 3 months without improvement in
symptoms.
She was presented acutely after 6 months with an attack of
hematemesis needing blood transfusion. Urgent endoscopic
examination of upper GIT showed nodular mucosal irregular-
ities in the fundus of stomach; esophagus, antrum, pylorus and
duodenum were normal. Mucosal biopsies revealed multiple
non caseating granulomas confirming the diagnosis of sarcoid-
osis. Stains for Helicobacter pylori, acid fast, and fungi were
negative, serum angiotensin converting enzyme was 74 units/l
(N 44–125 units/L), 24 h urine collection ruled out hypercalci-
uria. She was treated with prednisolone, metoclopramide, and
antacid and obtained relief of gastric symptoms, noted weight
gain and improvement in her energy level. The dose of
prednisolone was gradually tapered to a maintenance dose of
10–15 mg over a period of approximately 6 months, upper gas-
trointestinal barium study performed later showed a decrease
in gastric nodularity.Discussion
Sarcoidosis is a multisystem systemic granulomatous disease of
unknown etiology that most commonly affects young adults.
The disease is relatively rare in the pediatric population.The true incidence and prevalence of childhood sarcoidosis
is unknown because of the rarity of the disease and the small
number of reported cases in childhood.
Two distinct forms of childhood sarcoidosis appear to exist.
Older children usually present with a multisystem disease sim-
ilar to the adult manifestation with frequent lymphadenopathy
and pulmonary involvement, as well as generalized signs and
symptoms, such as fever, malaise, and weight loss. In contrast,
early-onset childhood sarcoidosis is a unique form of disease
characterized by the triad of rash, uveitis, and arthritis in chil-
dren who are younger than 5 years [3].
The lung is the organ most commonly involved in sarcoid-
osis. Pulmonary symptoms are usually mild and often consist
of a dry hacking cough, with or without dyspnea. Bilateral hi-
lar lymphadenopathy with or parenchymal involvement is the
most common radiographic finding as in our case [4].
Peripheral lymph node enlargement noted in 40–70% of
cases, is the most accessible site for diagnostic biopsy. Lymph
nodes are typically firm, non-tender, and freely movable.
Although hepatosplenomegaly may occur in up to 43% of pa-
tients with childhood sarcoidosis, clinical manifestations are
not as apparent [5].
Ocular involvement is common in childhood sarcoidosis.
Visual symptoms such as eye pain, blurry vision, photophobia,
and redness may be present in 29% of patients. Uveitis or iritis
is the most common manifestation of the children with sar-
coidosis. Slit lamp examination is mandatory in the evaluation
of childhood sarcoidosis [6].
An erythematous rash is commonly noted in childhood sar-
coidosis. The most frequent cutaneous eruptions include soft,
red to yellowish brown, or violaceous, flat-topped papules,
found most frequently on the face. Macular lesions with scar-
ring and ichthyosiform cutaneous manifestations are fre-
quently encountered [7].
Gastrointestinal tract sarcoidosis is rare and may present in
the context of generalized disease as in our case or as an iso-
lated finding. GI sarcoidosis commonly occurs subclinically,
with clinical manifestations present in only 0.1–0.9% of pa-
tients with the disease. Manifestations of the disease include
epigastric pain, nausea, vomiting, and are usually postpran-
dial. Weight loss is common, upper GI bleeding can also be
the initial presentation. Endoscopy may reveal ulcerations,
gastritis, or diffusely erythematous, friable mucosa that is ele-
vated over the surroundings. Nodular irregularities and muco-
sal polyps may be present occasionally. The diagnosis of
gastric sarcoidosis is dependent on histological evidence of sar-
coid granulomas on mucosal biopsies [8].
There is no laboratory test diagnostic of sarcoidosis. Labo-
ratory evaluation may reveal elevated erythrocyte sedimenta-
tion rate (ESR) or other acute phase reactants. Anemia,
leucopenia, and eosinophilia are commonly seen on blood
counts. Hypercalcemia and/or hypercalciuria may be found.
The serum level of angiotensin-converting enzyme (ACE) is
elevated in over 50% of children with late-onset sarcoidosis
[9]. Chest radiograph is very useful and may reveal bilateral hi-
lar adenopathy. High-resolution chest computed tomography
(CT) can be helpful in delineating the extent of parenchymal
disease and hilar adenopathy. The diagnosis of sarcoidosis is
confirmed by demonstrating a typical noncaseating epithelioid
cell granuloma on a biopsy specimen.
The current therapy of choice for childhood sarcoidosis with
multisystem involvement is corticosteroids. Oral prednisolone
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treatment. This treatment is continued until the clinical mani-
festations of the disease resolve or show significant improve-
ment, then slowly tapered over a period of 2–3 months to an
appropriate maintenance dose (10–15 mg per day as a once dai-
ly regimen) that is usually required for at least 6 months for
most age groups [10].
The disease activity is monitored clinically, radiographi-
cally, and by serum ACE levels. Some patients may relapse,
either during steroid taper or after discontinuation of the drug.
In such cases, steroid treatment should be restarted with a dos-
age similar to that used in the induction treatment. The overall
prognosis of childhood sarcoidosis is reported as good com-
pared with the prognosis for adults. Sarcoidosis in very young
children with involvement of eyes, joints and skin has a
guarded prognosis with the likelihood of a chronic progressive
course [11].
Conclusion
Gastric sarcoidosis should be considered in patients with sar-
coidosis who have gastric symptoms. Because of the subclinical
nature of disease, it may actually be much more common than
thought. It is therefore essential that histologic confirmation be
established so that symptoms may be treated appropriately as
they arise.References
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